CellSeed Inc logo

7776 - CellSeed Inc News Story

¥256 2.0  0.8%

Last Trade - 15/01/21

Sector
Healthcare
Size
Micro Cap
Market Cap £28.8m
Enterprise Value £20.8m
Revenue £1.05m
Position in Universe 3259th / 3893

TABLE-CellSeed -2018 group results

Fri 15th February, 2019 7:30am
Feb 15 (Reuters)- 
          CellSeed Inc. 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended      Year ended        Year to         NEXT     
                Dec 31, 2018    Dec 31, 2017    Dec 31, 2019       YEAR       
                   LATEST         YEAR-AGO         COMPANY         COMPANY    
                   RESULTS         RESULTS        FORECAST       H1 FORECAST  
  Sales             1.03           85 mln          300 mln         180 mln    
                                 (-15.5 pct)     (+29.2 pct)     (+51.7 pct)  
  Operating        140 mln      loss 956 mln      loss 1.10     loss 450 mln  
  Recurring        140 mln      loss 964 mln      loss 1.10     loss 450 mln  
  Net
  Net              129 mln      loss 966 mln      loss 1.10     loss 450 mln  
  EPS             11.35 yen    loss 93.29 yen  loss 95.99 yen  loss 39.27 yen 
  EPS Diluted     11.27 yen                                                   
  Ann Div            NIL             NIL             NIL                      
  -Q2 Div            NIL             NIL             NIL                      
  -Q4 Div            NIL             NIL             NIL                      
  
  NOTE - CellSeed Inc..
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=7776.T
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.